Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5X54

Crystal structure of the Keap1 Kelch domain in complex with a tetrapeptide

5X54 の概要
エントリーDOI10.2210/pdb5x54/pdb
分子名称Kelch-like ECH-associated protein 1, ACE-GLU-TRP-TRP-TRP, ACETATE ION, ... (4 entities in total)
機能のキーワードtranscription, complex, inhibitor, kelch domain, nrf2, oxidative stress, transcription-transcription inhibitor complex, transcription/transcription inhibitor
由来する生物種Homo sapiens (Human)
詳細
細胞内の位置Cytoplasm: Q14145
タンパク質・核酸の鎖数4
化学式量合計65178.68
構造登録者
Sogabe, S.,Kadotani, A.,Lane, W.,Snell, G. (登録日: 2017-02-14, 公開日: 2017-03-29, 最終更新日: 2024-10-09)
主引用文献Sogabe, S.,Sakamoto, K.,Kamada, Y.,Kadotani, A.,Fukuda, Y.,Sakamoto, J.
Discovery of a Kelch-like ECH-associated protein 1-inhibitory tetrapeptide and its structural characterization
Biochem. Biophys. Res. Commun., 486:620-625, 2017
Cited by
PubMed Abstract: Keap1 constitutively binds to the transcription factor Nrf2 to promote its degradation, resulting in negative modulation of genes involved in cellular protection against oxidative stress. Keap1 is increasingly recognized as an attractive target for treating diseases involving oxidative stress, including cancer, atherosclerosis, diabetes, arthritis, and neurodegeneration. We used phage-display peptide screening to identify a tetrapeptide showing moderate binding affinity, which inhibits the interaction between Nrf2 and Keap1. The tetrapeptide does not include an ETGE motif, which is a commonly found consensus sequence in known peptidic inhibitors. In addition to affinity parameters, IC, K, and thermodynamic parameters, the crystal structure of the complex was determined to elucidate the binding conformation. The binding interactions resemble those of known small-molecule inhibitors as opposed to those of substrates and peptidic inhibitors. Although the tetrapeptide's affinity is not very high, our results may help facilitate the designing of small-molecule inhibitors during lead generation in drug discovery.
PubMed: 28315327
DOI: 10.1016/j.bbrc.2017.03.038
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.3 Å)
構造検証レポート
Validation report summary of 5x54
検証レポート(詳細版)ダウンロードをダウンロード

229380

件を2024-12-25に公開中

PDB statisticsPDBj update infoContact PDBjnumon